A case report of remission of refractory membranous nephropathy progressing to stage 4 chronic kidney disease using low-dose rituximab: A long-term follow-up

Rationale: As suggested by the 2012 KDIGO guidelines, persistent elevation of serum creatinine> 3.5 mg/dl (> 309 μmol/l) (or an estimated glomerular filtration rate
Source: Medicine - Category: Internal Medicine Tags: Research Article: Clinical Case Report Source Type: research